NANO.PA

Nanobiotix S.A.

ParisEUREQUITY DELAYED

37.70

▲ 0.30 (0.80%)

MARKET · —

Price

Open

37.02

Prev close

37.40

Day high

38.30

Day low

36.60

Volume

76.36K

Market cap

—

P/E (TTM)

—

52W range

6.96 – 47.66

Trailing performance

Price return · vs SPY

Returnvs SPY

+17.77% +19.1%

+9.82% +6.1%

+7.58% +4.5%

+78.59% +67.5%

YTD

+95.08% +82.8%

+416.85% +396.8%

+331.78% +257.6%

+280.40% —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported

Market cap—

Enterprise value—

Revenue (TTM)—

Gross profit—

EBITDA—

Net income—

EPS (TTM)—

Free cash flow—

Total cash—

Total debt—

Book value / share—

Shares outstanding—

Float—

Short % of float—

Dividend yield—

Beta (5Y)—

Valuation & profitability ratios

Account required

Trailing P/E—

Forward P/E—

PEG ratio—

Price / sales—

Price / book—

EV / revenue—

EV / EBITDA—

Gross margin—

Operating margin—

Profit margin—

Return on equity—

Return on assets—

Debt / equity—

Current ratio—

Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Create free account Sign in

Analyst targets & ownership

Account required

Mean target—

High target—

Low target—

Implied upside—

Analyst count—

Consensus—

Strong buy / Buy— / —

Hold—

Sell / Strong sell— / —

Held by insiders—

Held by institutions—

Institutions holding—

Free account required

Price targets, consensus spread, insider and institutional ownership.

Create free account Sign in

Moving averages & technicals

Computed from 2Y daily closes

SMA 10

35.01

+7.67% from price

SMA 20

34.38

+10.66% from price

SMA 50

33.43

+13.79% from price

SMA 100

32.68

+15.37% from price

SMA 200

26.82

+41.83% from price

EMA 12

35.49

+6.23% from price

EMA 26

34.58

+9.03% from price

EMA 50

33.78

+11.60% from price

RSI (14)

63.0

Neutral

MACD (12,26,9)

0.91

Hist 0.48

ATR (14)

2.05

5.40% of price

Realised vol 30D

58.5%

Annualised

Bollinger upper

37.76

20, 2σ

Bollinger lower

30.99

20, 2σ

50 / 200 cross

Golden

33.43 vs 26.82

Trend bias

Above 200

+41.83%

Risk profile

Daily returns · 1Y window

Beta vs SPY

0.62

Less volatile than market

Correlation to SPY

0.09

Largely independent

Realised vol 30D

58.5%

Annualised

Market vol 1Y

12.9%

SPY, annualised

Max drawdown 1Y

-45.4%

Peak to trough

Max drawdown 5Y

-85.7%

Peak to trough

ATR 14

2.05

5.40% of price

Beta (reported)

—

5Y monthly, from filing

Options chain

Account required

ExpirySpot 37.70

Calls

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Puts

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Create free account Sign in

Headlines

NANO.PA · links out to the publisher

Insider Transaction: Cytokinetics CEO Robert Blum Sells 7,500 Shares for $575,700 Motley Fool · 9m ago Bear attacks, conflicts with humans reach historic levels in Colorado USA TODAY · 16m ago This Under-the-Radar Healthcare Stock Yields Nearly 8.5%. Here's Whether That Income Is Too Good to Be True. Motley Fool · 16m ago What Would Alan Greenspan Say About This Stock Market? Motley Fool · 16m ago One quantum stock just posted a 9,000% revenue jump TheStreet · 18m ago Lens hammer Auxerre thanks to Thauvin penalty double AFP · 21m ago Outside investigation into St. Paul mayor likely to be costly, with end date unknown Pioneer Press, St. Paul, Minn. · 25m ago Olise helps Bayern past Dortmund in German Supercup AFP · 27m ago

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.